Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
1(14%)
Results Posted
20%(1 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_2
5
71%
Ph phase_1
1
14%
Ph phase_3
1
14%

Phase Distribution

1

Early Stage

5

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
5(71.4%)
Phase 3Large-scale testing
1(14.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(5)
Terminated(1)

Detailed Status

Completed5
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
83.3%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (14.3%)
Phase 25 (71.4%)
Phase 31 (14.3%)

Trials by Status

completed571%
recruiting114%
terminated114%

Recent Activity

1 active trials
Showing 5 of 7
recruitingphase_2

Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS).

NCT07042516
completedphase_2

Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis

NCT02475447
completedphase_3

Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)

NCT01100684
terminatedphase_2

Asimadoline for the Treatment of Post-Operative Ileus

NCT00443040
completedphase_2

Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome

NCT00454688
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT07042516Phase 2

Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS).

Recruiting
NCT02475447Phase 2

Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis

Completed
NCT01100684Phase 3

Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)

Completed
NCT00443040Phase 2

Asimadoline for the Treatment of Post-Operative Ileus

Terminated
NCT00454688Phase 2

Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome

Completed
NCT01380561Phase 1

A Metabolite Identification, Mass Balance, and PK Study of [14C]-Asimadoline to Healthy Adult Male Volunteers

Completed
NCT00955994Phase 2

Effect of Asimadoline, a Member of a New Medication Class, on Acute Attacks of Pain in Irritable Bowel Syndrome

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7